We are live on ! Find out more
ELV icon

Elevance Health

1,704 hedge funds and large institutions have $107B invested in Elevance Health in 2024 Q3 according to their latest regulatory filings, with 137 funds opening new positions, 683 increasing their positions, 602 reducing their positions, and 130 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 683 | Existing positions reduced: 602

5% more first-time investments, than exits

New positions opened: 137 | Existing positions closed: 130

1% less funds holding

Funds holding: 1,714 → 1,704 (-10)

0.66% less ownership

Funds ownership: 89.53% → 88.87% (-0.66%)

4% less call options, than puts

Call options by funds: $620M | Put options by funds: $645M

6% less funds holding in top 10

Funds holding in top 10: 54 → 51 (-3)

17% less capital inflows, than outflows

Capital inflows: $5.06B | Capital outflows: $6.07B

Holders
1,704
Holders Change
-10
Holders Change %
-0.58%
% of All Funds
24.37%
Holding in Top 10
51
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-5.56%
% of All Funds
0.73%
New
137
Increased
683
Reduced
602
Closed
130
Calls
$620M
Puts
$645M
Net Calls
-$24.4M
Net Calls Change
-$15.8M

ELV Hedge Fund Activity: Q3 2024 in Review

1,704 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2024, worth a combined $107B — down 5.1% from $113B a quarter earlier.

Buyers outnumbered sellers: 137 funds opened new ELV positions and 130 closed out — a net gain of 7 holders — while 683 added to existing stakes and 602 trimmed.

The largest buyer was Invesco, adding an estimated $295M. The largest seller was T. Rowe Price Associates, cutting an estimated $797M.

  • 1,704 institutional investors held Elevance Health (ELV) as of Q3 2024, down from 1,714 in Q2 2024.
  • Funds reported $107B of Elevance Health stock for Q3 2024, down 5.1% quarter-over-quarter.
  • 137 funds opened new Elevance Health positions in Q3 2024 and 130 closed out, a net change of +7 holders.
  • The largest Elevance Health buyer in Q3 2024 was Invesco, an estimated $295M added.
  • The largest Elevance Health seller in Q3 2024 was T. Rowe Price Associates, an estimated $797M sold.

Based on aggregated 13F filings for Q3 2024.